Skip to content

Study of Acquired Hemolytic Anemia in Adult Hospitalized Patients

Study of the Etiology, Clinical Features and Short Term Outcome of Acquired Hemolytic Anemia in Hospitalized Adult Patients with Non-Neoplastic Disease

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06708728
Enrollment
60
Registered
2024-11-27
Start date
2024-12-31
Completion date
2025-06-30
Last updated
2024-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemolytic Anemia

Brief summary

the goal of the study is to identify the most common etiological factors and analyze the clinical presentations and laboratory findings in hospitalized patients with acquired hemolytic anemia associated with non-neoplastic diseases. And to evaluate short-term outcomes, including morbidity and mortality rates, and to determine correlations between specific etiological factors and patient outcomes in these cases.

Interventions

OTHERblood samples

blood samples for CBC parameters , peripheral blood smear, bilirubin levels and kidney function tests

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 years and older. * Patients diagnosed with acquired hemolytic anemia. * Patients must be hospitalized in the Internal Medicine department at the time of diagnosis of acquired hemolytic anemia during the study period * Patients (or their legal representatives) must provide informed

Exclusion criteria

* Patients with underlying neoplastic diseases. * Patients with hereditary hemolytic anemia. * Patients or their representatives who do not consent to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
intensive care unit admission of the patients due to progression of the disease complications.through study completion, an average of 6 monthsPrimary outcome will be ICU admission due to progression of the disease complications.

Secondary

MeasureTime frameDescription
mortality within duration of hospital admissionthrough study completion, an average of 6 monthsSecondary outcome will be mortality within duration of hospital admission

Countries

Egypt

Contacts

Primary ContactAhmed E Mahmoud
ahmed.elsayed95@med.sohag.edu.eg02 01145943157
Backup ContactMahmoud I Yousef, Lecturer of Internal Medicine
02 0106 596 4083

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026